AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Akebia Therapeutics to Present at the 18th Annual Needham Healthcare Conference

April 5, 2019

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 5, 2019--Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for patients with kidney disease, today announced that John P. Butler, President and Chief Executive Officer, will present at the 18 th Annual Needham Healthcare Conference on Tuesday, April 9, 2019 at 11:20 a.m. Eastern Time in New York.

A live webcast of the presentation will be available on the company’s website at  www.akebia.com. To access, please log onto the Akebia website at least 15 minutes prior to the webcast to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Akebia’s website following the conference.

About Akebia Therapeutics

Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company focused on the development and commercialization of therapeutics for patients with kidney disease. The company was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at  www.akebia.com, which does not form a part of this release.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190405005460/en/

CONTACT: Kristen K. Sheppard, Esq

VP, Investor Relations

ksheppard@akebia.com

KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS NEW YORK

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL

SOURCE: Akebia Therapeutics, Inc.

Copyright Business Wire 2019.

PUB: 04/05/2019 04:19 PM/DISC: 04/05/2019 04:19 PM

http://www.businesswire.com/news/home/20190405005460/en